tykhr
sign in
free sign up
Madrigal Pharmaceuticals Inc
Biotechnology
Healthcare
MDGL
22.09 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
441.56
52 week high
453.80
high
452.01
52 week low
0.00
low
439.97
growth
89.87 %
previous Close
440.07
P/E ratio
market cap
6.71 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
53.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top